These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 17706797)
1. Recovery from cisplatin-induced ototoxicity: a case report and review. Truong MT; Winzelberg J; Chang KW Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1631-8. PubMed ID: 17706797 [TBL] [Abstract][Full Text] [Related]
2. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected. Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725 [TBL] [Abstract][Full Text] [Related]
3. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters. Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218 [TBL] [Abstract][Full Text] [Related]
4. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment. Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin ototoxicity in children: implications for primary care providers. Helt-Cameron J; Allen PJ Pediatr Nurs; 2009; 35(2):121-7. PubMed ID: 19472677 [TBL] [Abstract][Full Text] [Related]
6. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission. Biro K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I Oncology; 2006; 70(3):177-84. PubMed ID: 16757924 [TBL] [Abstract][Full Text] [Related]
7. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. Knight KR; Kraemer DF; Neuwelt EA J Clin Oncol; 2005 Dec; 23(34):8588-96. PubMed ID: 16314621 [TBL] [Abstract][Full Text] [Related]
8. [Clinical study on the ototoxicity of cisplatin with distortion products]. Orts Alborch M; García Callejo J; Morant Ventura A; Ferrer Baixauli F; Esparcia Navarro M; Marco Algarra J Acta Otorrinolaringol Esp; 2000; 51(6):469-77. PubMed ID: 11142781 [TBL] [Abstract][Full Text] [Related]
9. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy. Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939 [TBL] [Abstract][Full Text] [Related]
10. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives. Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780 [TBL] [Abstract][Full Text] [Related]
11. Recovery of hearing following cisplatin ototoxicity in the guinea pig. O'Leary SJ; Klis SF Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832 [TBL] [Abstract][Full Text] [Related]
12. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)]. Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950 [TBL] [Abstract][Full Text] [Related]
14. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. Knight KR; Kraemer DF; Winter C; Neuwelt EA J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008 [TBL] [Abstract][Full Text] [Related]
15. Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin. Peters U; Preisler-Adams S; Lanvers-Kaminsky C; Jürgens H; Lamprecht-Dinnesen A Anticancer Res; 2003; 23(2B):1249-55. PubMed ID: 12820379 [TBL] [Abstract][Full Text] [Related]
16. Ototoxicity in children treated for osteosarcoma. Lewis MJ; DuBois SG; Fligor B; Li X; Goorin A; Grier HE Pediatr Blood Cancer; 2009 Mar; 52(3):387-91. PubMed ID: 19061216 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Rybak LP Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555 [TBL] [Abstract][Full Text] [Related]
18. [Ototoxicity of cisplatin in children with malignant diseases]. Hadjilaskari P; Fengler R; Hartmann R; Henze G Klin Padiatr; 1989; 201(4):316-21. PubMed ID: 2779137 [TBL] [Abstract][Full Text] [Related]
19. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819 [TBL] [Abstract][Full Text] [Related]
20. [Cochlear-vestibular ototoxicity by gentamicin. Report of a case and literature review]. Pino Rivero V; Marcos García M; Keituqwa Yáñez T; González Palomino A; Trinidad Ruiz G; Pardo Romero G; Blasco Huelva A An Otorrinolaringol Ibero Am; 2004; 31(6):531-7. PubMed ID: 15663084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]